Alpa Laboratories Limited(IN:ALPA)
₹55.61+0.05 (+0.09%)
IN:ALPA
Alpa Laboratories Limited financials statements
₹55.61
At close:+0.05 (+0.09%)
Want to see IN:ALPA full AI Analyst Report?
Alpa Laboratories Limited (ALPA) Ratios
3 Followers
Alpa Laboratories Limited Ratios
IN:ALPA's free cash flow for Q1 2027 was ₹0.00. For the 2027 fiscal year, IN:ALPA's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.01 | 4.10 | 5.68 | 5.03 | 4.40 |
| Quick Ratio | 3.76 | 3.72 | 5.19 | 4.61 | 3.90 |
| Cash Ratio | 0.05 | 0.05 | 0.06 | 0.30 | 0.05 |
| Solvency Ratio | 0.31 | 0.42 | 0.61 | 0.43 | 0.47 |
| Operating Cash Flow Ratio | 0.24 | 0.20 | 0.13 | 0.30 | 0.32 |
| Short-Term Operating Cash Flow Coverage | 4.96 | 269.31 | 0.70 | 5.83 | 2.67 |
| Net Current Asset Value | ₹ 1.55B | ₹ 1.40B | ₹ 1.30B | ₹ 1.16B | ₹ 1.05B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.00 | 0.03 | 0.01 | 0.04 |
| Debt-to-Equity Ratio | 0.01 | 0.00 | 0.03 | 0.02 | 0.05 |
| Debt-to-Capital Ratio | 0.01 | 0.00 | 0.03 | 0.02 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
| Financial Leverage Ratio | 1.30 | 1.30 | 1.20 | 1.24 | 1.28 |
| Debt Service Coverage Ratio | 6.28 | 82.44 | 3.41 | 8.08 | 4.05 |
| Interest Coverage Ratio | 4.64 | 11.01 | 17.13 | 30.20 | 43.55 |
| Debt to Market Cap | 0.03 | 0.00 | 0.03 | 0.02 | 0.04 |
| Interest Debt Per Share | 1.31 | 0.13 | 2.68 | 1.20 | 2.88 |
| Net Debt to EBITDA | -0.02 | -0.08 | 0.15 | -0.37 | 0.20 |
| Profitability Margins | |||||
| Gross Profit Margin | 12.86% | 17.25% | 17.37% | 33.27% | 31.13% |
| EBIT Margin | 16.02% | 23.03% | 19.35% | 17.44% | 17.80% |
| EBITDA Margin | 18.00% | 24.99% | 21.15% | 18.88% | 19.39% |
| Operating Profit Margin | 1.13% | 2.27% | 5.66% | 7.30% | 8.63% |
| Pretax Profit Margin | 15.78% | 22.82% | 19.02% | 17.20% | 17.70% |
| Net Profit Margin | 14.19% | 17.34% | 15.43% | 13.62% | 12.75% |
| Continuous Operations Profit Margin | 14.19% | 17.34% | 15.43% | 13.62% | 12.75% |
| Net Income Per EBT | 89.89% | 75.99% | 81.12% | 79.19% | 72.04% |
| EBT Per EBIT | 1393.29% | 1006.15% | 336.21% | 235.51% | 205.03% |
| Return on Assets (ROA) | 6.20% | 8.76% | 9.20% | 7.52% | 9.08% |
| Return on Equity (ROE) | 8.06% | 11.38% | 11.04% | 9.35% | 11.58% |
| Return on Capital Employed (ROCE) | 0.63% | 1.45% | 3.99% | 4.90% | 7.70% |
| Return on Invested Capital (ROIC) | 0.56% | 1.10% | 3.14% | 3.84% | 5.39% |
| Return on Tangible Assets | 6.20% | 8.76% | 9.20% | 7.53% | 9.08% |
| Earnings Yield | 15.35% | 8.69% | 8.86% | 11.12% | 9.61% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.56 | 2.22 | 2.61 | 1.98 | 3.01 |
| Payables Turnover | 5.18 | 4.98 | 3.99 | 4.10 | 5.10 |
| Inventory Turnover | 6.92 | 5.28 | 5.46 | 4.88 | 4.92 |
| Fixed Asset Turnover | 5.26 | 5.46 | 9.53 | 13.28 | 11.99 |
| Asset Turnover | 0.44 | 0.51 | 0.60 | 0.55 | 0.71 |
| Working Capital Turnover Ratio | 0.70 | 0.81 | 0.86 | 0.82 | 1.13 |
| Cash Conversion Cycle | 125.03 | 160.37 | 115.49 | 170.28 | 123.65 |
| Days of Sales Outstanding | 142.68 | 164.50 | 140.09 | 184.59 | 121.06 |
| Days of Inventory Outstanding | 52.78 | 69.19 | 66.86 | 74.82 | 74.16 |
| Days of Payables Outstanding | 70.43 | 73.33 | 91.46 | 89.13 | 71.57 |
| Operating Cycle | 195.46 | 233.69 | 206.95 | 259.41 | 195.23 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5.91 | 4.39 | 1.74 | 4.23 | 4.72 |
| Free Cash Flow Per Share | 4.03 | -1.02 | -1.31 | 3.70 | 3.68 |
| Dividend Paid and CapEx Coverage Ratio | 3.15 | 0.81 | 0.57 | 7.91 | 4.54 |
| Capital Expenditure Coverage Ratio | 3.15 | 0.81 | 0.57 | 7.91 | 4.54 |
| Operating Cash Flow Coverage Ratio | 4.96 | 269.31 | 0.70 | 3.86 | 1.70 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.08 | 0.03 | 0.10 | 0.09 |
| Free Cash Flow Yield | 8.68% | -0.95% | -1.44% | 6.87% | 5.28% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 6.52 | 11.50 | 11.29 | 9.00 | 10.41 |
| Price-to-Sales (P/S) Ratio | 0.92 | 2.00 | 1.74 | 1.22 | 1.33 |
| Price-to-Book (P/B) Ratio | 0.52 | 1.31 | 1.25 | 0.84 | 1.20 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 11.52 | -104.73 | -69.23 | 14.55 | 18.92 |
| Price-to-Operating Cash Flow Ratio | 7.86 | 24.29 | 51.92 | 12.71 | 14.75 |
| Price-to-Earnings Growth (PEG) Ratio | -0.28 | 0.73 | 0.33 | -0.84 | 0.11 |
| Enterprise Value Multiple | 5.12 | 7.91 | 8.39 | 6.12 | 7.04 |
| Enterprise Value | 974.26M | 2.22B | 1.93B | 1.07B | 1.51B |
| EV to EBITDA | 5.12 | 7.91 | 8.39 | 6.12 | 7.04 |
| EV to Sales | 0.92 | 1.98 | 1.77 | 1.15 | 1.37 |
| EV to Free Cash Flow | 11.48 | -103.73 | -70.52 | 13.72 | 19.48 |
| EV to Operating Cash Flow | 7.83 | 24.06 | 52.89 | 11.98 | 15.18 |
| Tangible Book Value Per Share | 88.52 | 81.44 | 72.50 | 63.92 | 57.81 |
| Shareholders’ Equity Per Share | 88.53 | 81.46 | 72.53 | 63.96 | 57.86 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.10 | 0.24 | 0.19 | 0.21 | 0.28 |
| Revenue Per Share | 50.29 | 53.44 | 51.92 | 43.92 | 52.52 |
| Net Income Per Share | 7.13 | 9.27 | 8.01 | 5.98 | 6.70 |
| Tax Burden | 0.90 | 0.76 | 0.81 | 0.79 | 0.72 |
| Interest Burden | 0.98 | 0.99 | 0.98 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.12 | 0.15 | 0.01 | 0.01 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.83 | 0.47 | 0.22 | 0.57 | 0.51 |
Currency in INR
